Patients with hypertension-associated thrombotic microangiopathy may present with complement abnormalities

Sjoerd A. M. E. G. Timmermans, Myrurgia A. Abdul-Hamid, Joris Vanderlocht, Jan G. M. C. Damoiseaux, Chris P. Reutelingsperger, Pieter van Paassen*, Limburg Renal Registry

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1420-1425
Number of pages6
JournalKidney International
Volume91
Issue number6
DOIs
Publication statusPublished - Jun 2017

Keywords

  • atypical hemolytic uremic syndrome
  • complement dysregulation
  • genetics
  • malignant hypertension
  • thrombotic microangiopathy
  • HEMOLYTIC-UREMIC SYNDROME
  • FACTOR-H
  • RENAL-TRANSPLANTATION
  • INHIBITOR ECULIZUMAB
  • CLINICAL PHENOTYPE
  • GENE-MUTATIONS
  • C3 MUTATION
  • AHUS
  • ACTIVATION
  • RECURRENCE

Cite this